Chêne G - Search Results

1

[Lopinavir/ritonavir in HIV-infected patient with long-term virological failure: immunovirological response and tolerance in 121 patients of the ANRS CO8 Aproco-Copilote cohort].

Brunet-François C, Taieb A, Masquelier B, Le Moing V, Lewden C, Dellamonica P, Cuzin L, Allavena C, Spire B, Chêne G, Raffi F; Groupe d'Etude Aproco-Copilote (ANRS C08). Brunet-François C, et al. Among authors: chene g. Med Mal Infect. 2007 Mar;37(3):172-7. doi: 10.1016/j.medmal.2006.11.003. Epub 2007 Jan 17. Med Mal Infect. 2007. PMID: 17239554 French.

2

[Risk factors of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention].

Leport C, Ambroise-Thomas P, Bazin C, Chène G, Derouin F, Katlama C, Mayaud C, Pelloux H, Raffi F, Vildé JL. Leport C, et al. Among authors: chene g. Ann Med Interne (Paris). 1996;147(5):331-2. Ann Med Interne (Paris). 1996. PMID: 9033735 Review. French. No abstract available.

3

Acquired immunodeficiency syndrome-associated Kaposi's sarcoma and human herpesvirus 8 DNA detection in serial peripheral blood mononuclear cell samples.

Dupon M, Masquelier B, Cazorla C, Chêne G, Dumon B, Ragnaud JM, de Barbeyrac B, Bébéar C, Lacut JY, Fleury HJ. Dupon M, et al. Among authors: chene g. Res Virol. 1997 Nov-Dec;148(6):417-25. doi: 10.1016/s0923-2516(97)83631-x. Res Virol. 1997. PMID: 9498013

4

Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients.

Molina JM, Ferchal F, Rancinan C, Raffi F, Rozenbaum W, Sereni D, Morlat P, Journot V, Decazes JM, Chêne G. Molina JM, et al. Among authors: chene g. J Infect Dis. 2000 Aug;182(2):599-602. doi: 10.1086/315711. Epub 2000 Jul 13. J Infect Dis. 2000. PMID: 10915095 Clinical Trial.

5

Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group.

Savès M, Raffi F, Clevenbergh P, Marchou B, Waldner-Combernoux A, Morlat P, Le Moing V, Rivière C, Chêne G, Leport C. Savès M, et al. Among authors: chene g. Antimicrob Agents Chemother. 2000 Dec;44(12):3451-5. doi: 10.1128/AAC.44.12.3451-3455.2000. Antimicrob Agents Chemother. 2000. PMID: 11083658 Free PMC article.

6

Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy: standardization to the general population.

Lewden C, Raffi F, Chêne G, Sobel A, Leport C; APROCO Study Group. Lewden C, et al. Among authors: chene g. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):480-2. doi: 10.1097/00126334-200104150-00013. J Acquir Immune Defic Syndr. 2001. PMID: 11391169 Clinical Trial.

7

Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors.

Le Moing V, Chêne G, Carrieri MP, Besnier JM, Masquelier B, Salamon R, Bazin C, Moatti JP, Raffi F, Leport C; APROCO Study Group. Le Moing V, et al. Among authors: chene g. J Acquir Immune Defic Syndr. 2001 Aug 1;27(4):372-6. doi: 10.1097/00126334-200108010-00007. J Acquir Immune Defic Syndr. 2001. PMID: 11468425

8

Progression to AIDS or death as endpoints in HIV clinical trials.

Raffi F, Chêne G, Lassalle R, May T, Billaud E, Fleury H, Dellamonica P, Leport C; APROCO Study Group. Anti-protease cohort. Raffi F, et al. Among authors: chene g. HIV Clin Trials. 2001 Jul-Aug;2(4):330-5. doi: 10.1310/Q2L2-QVRK-4E01-C8F8. HIV Clin Trials. 2001. PMID: 11590536

9

Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA.

Masquelier B, Neau D, Chêne G, Larbère J, Birac V, Ragnaud JM, Fleury HJ. Masquelier B, et al. Among authors: chene g. J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):309-12. doi: 10.1097/00126334-200112010-00001. J Acquir Immune Defic Syndr. 2001. PMID: 11707665 Clinical Trial.

10

Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.

Bonnet F, Morlat P, Chêne G, Mercié P, Neau D, Chossat I, Decoin M, Djossou F, Beylot J, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Bonnet F, et al. Among authors: chene g. HIV Med. 2002 Jul;3(3):195-9. doi: 10.1046/j.1468-1293.2002.00117.x. HIV Med. 2002. PMID: 12139658 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

774 results

Search Page

Filters